Mumbai, Sept. 9 -- Under the terms of the agreement, Strides will collaborate with Kenox on the development and regulatory filing of multiple nasal spray products for the US market, spanning various therapeutic indications.

The partnership aims to leverage Kenox's specialized expertise in OINDPs and Strides' strong presence in regulated markets.

"We are delighted to announce this partnership with Kenox, a company that brings deep technical expertise in the OINDP space," said Aditya Kumar, executive director - business development, Strides Pharma Science. "Nasal sprays have consistently been a key focus area for Strides, and this collaboration builds on the solid progress we've already made in this domain. With our continued investments ...